Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 1, 1998, Pages 1-9

  Kwa, Stefan L S ^a   Lebesque, Joos V ^a   Theuws, Jacqueline C M ^a   Marks, Lawrence B ^b   Munley, Mike T ^b   Bentel, Gunilla ^b   Oetzel, Dieter ^c   Spahn, Uwe ^c   Graham, Mary V ^d   Drzymala, Robert E ^d   Purdy, James A ^d   Lichter, Allen S ^e   Martel, Mary K ^e   Ten Haken, Randall K ^e  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Dose volume histogram; Lung; Mean dose; Normal tissue complication probability; Radiation pneumonitis

Indexed keywords

ARTICLE; HISTOGRAM; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION HAZARD; RADIATION PNEUMONIA; RISK ASSESSMENT; SCORING SYSTEM;

EID: 0031688620     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00196-5     Document Type: Article

References (22)

1. Jackson A, Kutcher GJ, Yorke ED. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys 1993;20: 613-625.
2. Kutcher GJ, Burman C, Brewster MS, Goitein M, Mohan R. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 1991;21:137-146.
3. Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res 1995;104:S13-S19.
4. Niemierko A, Goitein M. Modeling of normal tissue response to radiation: The critical volume model. Int J Radiat Oncol Biol Phys 1992;25:135-145.
5. Yorke ED, Kutcher GJ, Jackson A, Ling CC. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol 1993;26:226-237.
6. Graham MV, Dryzmala RE, Jain NL, Purdy JP. Confirmation of dose-volume histograms and normal tissue complication probability calculations to predict pulmonary complications after radiotherapy for lung cancer (abstr.). Int J Radiat Oncol Biol Phys 1994;30(S1):198.
7. Marks LB, Munley MT, Bentel GC, Zhou SM, Hollis D, Scarfone C, Sibley GS, Kong FM, Jirtle R, Jaszczak R, Coleman RE, Tapson V, Anscher M. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 1997;39:563-570.
8. Martel, MK, Ten Haken RK, Hazuka MB, Turrisi AT, Fraass BA, Lichter AS. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 1994;28:575-581.
9. Oetzel D, Schraube P, Hensley F, Sroka-Pérez G, Menke M, Flentje M. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 1995;33:455-460.
10. Cox, JD, Azarnia N, Byhardt RW, Shin KH, Emami B, Pajak TF. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with >69.6 Gy in favorable patients with Radiation Therapy Oncology Group Stage III nonsmall-cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 1990;8:1543-1555.
11. Gross, NJ. Pulmonary effects of radiation therapy. Ann Intern Med 1977;86:81-92.
12. Maasilta P. Radiation-induced lung injury. From the chest physician's point of view. Lung Cancer 1991;7:367-384.
13. Wong, JW, Purdy JA. On methods of inhomogeneity corrections for photon transport. Med Phys 1990;17:807-814.
14. Lebesque JV, Keus RB. The simultaneous boost technique: The concept of relative normalized total dose. Radiother Oncol 1991;22:45-55.
15. Newcomb CH, Van Dyk J, Hill RP. Evaluation of isoeffect formulae for predicting radiation-induced lung damage. Radiother Oncol 1993;26:51-63.
16. Van Dyk J, Mah K, Keane TJ. Radiation-induced lung damage: Dose-time-fractionation considerations. Radiother Oncol 1989;14:55-69.
17. Maciejewski B, Taylor JM, Withers HR. Alpha/beta and the importance of the size of dose per fraction for late complications in the supraglottic larynx. Radiother Oncol 1986;7:323-326.
18. Kwa SLS, Theuws JCM, Wagenaar A, Damen EMF, Boersma LJ, Baas P, Muller SH, Lebesque JV. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol 1998. In press.
19. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function, Int J Radiat Oncol Biol Phys 1991;21:123-135.
20. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. Tolerance of normal tissue to therapeutic irradiation, Int J Radiat Oncol Biol Phys 1991;21:109-122.
21. Clayton D, Hills M. Statistical models in epidemiology. New York: Oxford University Press; 1993: Chapters 3 and 13.
22. Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 1996;24:103-110.